{
    "Trade/Device Name(s)": [
        "\u03b2eta-2-Microglobulin"
    ],
    "Submitter Information": "Beckman Coulter Ireland, Inc.",
    "510(k) Number": "K161297",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991136"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZG"
    ],
    "Summary Letter Date": "May 5, 2016",
    "Summary Letter Received Date": "May 9, 2016",
    "Submission Date": "May 5, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.5630"
    ],
    "Regulation Name(s)": [
        "Beta-2-microglobulin immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Beta-2-Microglobulin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter AU400",
        "AU400\u00ae",
        "AU480",
        "AU600",
        "AU640",
        "AU640\u00ae",
        "AU680",
        "AU2700",
        "AU5400",
        "AU5800"
    ],
    "Method(s)/Technology(ies)": [
        "Immunological test system",
        "Turbidimetric method"
    ],
    "Methodologies": [
        "Immunological testing",
        "Turbidimetric assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for \u03b2eta-2-Microglobulin reagent kit for quantitative determination of beta-2-microglobulin in human serum using turbidimetric immunological methods on Beckman Coulter AU analyzers",
    "Indications for Use Summary": "System reagent for the quantitative determination of beta-2-microglobulin in human serum on Beckman Coulter AU analyzers; for in vitro diagnostic use only",
    "fda_folder": "Immunology"
}